Ascensia Diabetes Care

Ascensia Diabetes Care

Basel, Switzerland· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $300M

Overview

Ascensia Diabetes Care is a global, pure-play diabetes company focused on diagnostics and digital health solutions. It operates as a subsidiary of PHC Holdings, having been formed through the acquisition of Bayer Diabetes Care in 2016. The company's core business revolves around its CONTOUR brand of blood glucose monitoring systems and complementary digital tools for diabetes management. With a strong commercial footprint and a patient-centric approach, Ascensia aims to innovate within the diabetes care continuum while integrating ESG principles into its corporate strategy.

Diabetes

Technology Platform

Blood glucose monitoring (BGM) systems and integrated digital health platforms for diabetes management. Core technology focuses on high-accuracy meter systems (CONTOUR portfolio) and complementary software solutions for data tracking and trend analysis.

Funding History

1
Total raised:$300M
Debt$300M

Opportunities

The global rise in diabetes prevalence ensures sustained demand for monitoring solutions.
The shift towards digital health and connected devices allows Ascensia to expand from hardware into higher-margin software and data services, creating recurring revenue streams and deeper patient engagement.

Risk Factors

Intense competition from both low-cost BGM manufacturers and advanced continuous glucose monitoring (CGM) systems threatens market share.
Heavy reliance on the traditional BGM segment and the CONTOUR brand creates portfolio concentration risk, making the company vulnerable to technological disruption.

Competitive Landscape

Ascensia competes in a crowded diabetes diagnostics market against major players like Roche (Accu-Chek), Abbott (FreeStyle), LifeScan (OneTouch), and emerging CGM leaders such as Dexcom and Medtronic. Its position relies on brand heritage, accuracy, and a global distribution network, but it faces pressure from both low-cost alternatives and innovative sensor-based technologies.